
Classified by the SEC under business services, nec.
Visa at a glance: how it scores on value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.
A mixed picture - strengths and real weaknesses - 21 of 29 checks passed.
What you pay today for what the business produces, measured against V's own history and its peers, never a universal rule.
Not enough data to score this fairly - the checks below show exactly what's missing.
Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.
| – | Cheaper than its own history (earnings) | no multiple history |
| ✕ | Earnings yield beats a long bond (4%) | 3.2% vs 4.0% |
| – | Better cash yield than its own history | under 3 years of cash-flow history |
| ✓ | Free cash flow yield above 3% | 3.0% vs 3.0% |
| ✕ | Cheap on enterprise value | 25.80 vs 14.00 (peer median) |
| – | Price isn't outrunning growth | no positive 3-year earnings growth to compare against |
What the company has actually reported - is it selling more, and is more of it becoming profit?
Growth is weak or inconsistent - the trend, not the story, is the problem.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $40.0B in 2025, compounding +11% a year since 2022 and the pace is picking up. The trailing twelve months are already running at $43.0B, ahead of the last full year.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $20.1B in 2025, compounding +10% a year over three years. Trailing twelve-month profit stands at $22.2B.
+11%revenue growth, FY 2025
→In 2025 revenue grew +11% while earnings moved +2% - when the earnings line runs above revenue, each new dollar of sales is arriving more profitably.
Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).
| ✕ | Outgrew its sector last year | 14.4% vs 15.8% (sector 70th pct, n=404) |
| ✕ | Sustained growth beats its sector (3 years) | 10.9% vs 17.6% (sector 70th pct, n=373) |
| ✓ | Profits grew last year | 11.8% vs 0.0% |
| – | Profit growth beats its peers | earnings at or below zero at either end |
| ✓ | Growth is speeding up, not slowing | 1y 14.4% vs 3y 10.9% |
| – | Grew per share, not just in total | under 3 years of per-share history |
Whether the growth makes real money - margins, returns on capital, and whether profits turn into cash.
Rare profitability: margins and returns on capital are well above its peers.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→Operating margin compressed 4 points to 60% since 2022. After everything, 50 cents of each sales dollar reaches net profit. V doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→Operating cash flow tracks reported profit almost exactly (102%). The earnings are real cash, not accounting.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→ROE 52% and ROCE 37% sit close together - the returns come from the business itself, not from borrowing.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→54 cents of every sales dollar became free cash in 2025, down 7 points since 2022.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-03-31), not a full fiscal year
→The biggest claim on each sales dollar is capital spending, at 4% of revenue (stock compensation 2%).
→Operating profit outgrew revenue in 3 of the last 5 years, most recently +2% against +11%. Each additional dollar of sales is landing more profitably than the last - the definition of operating leverage.
→V earns 36.7% on the capital it employs, well above the 10% most investors treat as the cost of capital. It was 28.5% in 2022, so the trend is up, and the pace is picking up.
Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.
| – | Better gross margins than peers | gross profit not tagged in its filings |
| ✓ | Runs leaner than peers (operating margin) | 61.1% vs 11.0% (sector 70th pct, n=398) |
| ✓ | Actually profitable | TTM net income $22.2B |
| ✓ | Earns well on shareholders' money | 62.4% vs 13.3% (sector 70th pct, n=346) |
| ✓ | Earns a real return on the capital it employs | 39.9% vs 10.0% |
| ✓ | Profits are cash, not accounting | 1.02 vs 0.80 |
The balance sheet stress test: could V survive a bad year?
Financially sound overall, with one or two things worth watching.
→Debt of $24.0B sits against $12.4B of cash, or 0.7x shareholders' equity. Earnings cover the interest bill 42 times over, so the debt is comfortably serviced.
→The company's own capital shrank from $39.7B in 2023 to $35.7B (-10%). Buybacks or losses are drawing the buffer down - the distinction matters.
Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.
| ✕ | Comfortable near-term liquidity | 1.09 vs 1.50 |
| ✓ | Debt isn't dominating | 0.67 vs 1.00 |
| ✕ | Debt trending the right way | debt/equity 0.67 now vs 0.58 five years ago |
| ✓ | Earnings cover the interest | 42.34 vs 5.00 |
| ✓ | Converts sales to cash better than its sector | 52.9% vs 23.1% (sector 70th pct, n=410) |
| ✓ | Self-funding | TTM free cash flow $21.2B |
How much cash actually flows back to owners - dividends, buybacks, whether the share count truly falls, and whether what is handed back is affordable.
Cash comes back to owners, with a caveat or two in the checks below.
→$22.9B returned last year against $897M of stock issued to employees - the returns outweigh the dilution 25.6-to-1.
A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.
| – | Share count isn't climbing | under 3 years of share counts |
| ✓ | Buybacks outpace the stock issued to staff | $21.3B bought back vs $920M of stock compensation |
| ✕ | What it hands back fits inside its cash flow | 123.7% vs 100.0% |
| ✓ | Meaningful yield to owners (dividends and buybacks) | $26.2B returned, 3.7% of market value |
| ✓ | Reliable payer, never cut | paid 10/10 years, worst year-on-year change 5.0% |
| ✓ | Dividend growing ahead of inflation | 44.7% vs 9.0% |
What the market is doing about all of the above. This is price behaviour, not a fact about the business - read it as the market's current opinion, scored on six checks like every other chapter. The market is the S&P 500, measured by the SPY ETF with dividends included, over 3 months (63 trading sessions) and 12 months (252).
The market agrees: the stock is in a healthy uptrend on every horizon.
Chart by TradingView
→V is in a clear uptrend. The price is above the band where recent trading settled, and that band is still rising underneath it, so the floor keeps moving up. It has held that side of the band for 59 sessions, so this is well established. The last two weeks are running ahead of the last month and the price is above where it stood a month ago, so the shorter-term readings back the trend up.
The trend read comes from the daily Ichimoku picture, a standard trend indicator, translated out of its jargon. It builds a band from the midpoints of the last 9, 26 and 52 sessions' highs and lows - in effect, the range where recent trading has settled - and draws that band 26 sessions into the future. Price above the band is an uptrend, below it a downtrend, inside it no trend. Because the band is drawn forward, the support for the next few weeks is already fixed and a change of its direction can be seen coming. We also compare the last two weeks against the last month, and today's price against where it stood a month ago. None of this says anything about the business; it describes the price only, and it is not advice. Where a check says 'the S&P 500', the comparison is with the SPY ETF including dividends, on the same adjusted basis as the stock's own price: short means 3 months, 63 trading sessions; long means 12 months, 252.
| ✓ | In an uptrend | 375.07 vs 332.93 |
| ✓ | Trend structure is healthy | 362.78 vs 332.93 |
| ✓ | Rising over 3 months | 16.1% vs 0.0% |
| ✓ | Beating the S&P 500 over 3 months | 16.1% vs 4.7% |
| ✕ | Beating the S&P 500 over 12 months | 7.7% vs 20.0% |
| ✓ | Not in a deep hole | -2.4% from its 52-week high |
What the people running the company do with their own shares - reported to the SEC within two days, classified so pay-plumbing doesn't masquerade as conviction.
→No open-market buying, and $77M of selling across 9 months. Selling alone is a weak signal - much of it is pre-scheduled - but the absence of buying tells you no insider saw the price as a bargain.
| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Ryan Mcinerney | Chief Executive Officer | exercise | 5,875 | $791,715 |
| 2026-09-01 | Ryan Mcinerney | Chief Executive Officer | SELL | 5,875 | $2M |
| 2026-08-31 | Julie B Rottenberg | GENERAL COUNSEL | exercise | 2,028 | $222,715 |
| 2026-08-31 | Julie B Rottenberg | GENERAL COUNSEL | SELL | 2,028 | $773,378 |
| 2026-08-21 | Rajat Taneja | PRESIDENT, TECHNOLOGY | SELL | 17,927 | $7M |
| 2026-08-21 | Ryan Mcinerney | Chief Executive Officer | exercise | 5,875 | $791,715 |
| 2026-08-21 | Ryan Mcinerney | Chief Executive Officer | SELL | 5,875 | $2M |
| 2026-08-15 | Peter M Andreski | GBL CORP CONTROLLER, CAO | tax | 1,714 | $624,153 |
| 2026-08-15 | Chris Suh | CHIEF FINANCIAL OFFICER | tax | 6,992 | $3M |
| 2026-07-30 | Tullier Kelly Mahon | VICE CHAIR, CHF PPL & CORP AFF | exercise | 37,281 | $4M |
Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.